GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » QuidelOrtho Corp (FRA:QL1A) » Definitions » Cyclically Adjusted Price-to-FCF

QuidelOrtho (FRA:QL1A) Cyclically Adjusted Price-to-FCF : 8.23 (As of May. 31, 2024)


View and export this data going back to 2005. Start your Free Trial

What is QuidelOrtho Cyclically Adjusted Price-to-FCF?

As of today (2024-05-31), QuidelOrtho's current share price is €40.80. QuidelOrtho's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was €4.96. QuidelOrtho's Cyclically Adjusted Price-to-FCF for today is 8.23.

The historical rank and industry rank for QuidelOrtho's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

FRA:QL1A' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 7.26   Med: 50.93   Max: 288.23
Current: 8.2

During the past years, QuidelOrtho's highest Cyclically Adjusted Price-to-FCF was 288.23. The lowest was 7.26. And the median was 50.93.

FRA:QL1A's Cyclically Adjusted Price-to-FCF is ranked better than
93.62% of 235 companies
in the Medical Devices & Instruments industry
Industry Median: 43.83 vs FRA:QL1A: 8.20

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

QuidelOrtho's adjusted free cash flow per share data for the three months ended in Mar. 2024 was €-0.919. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is €4.96 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


QuidelOrtho Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for QuidelOrtho's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

QuidelOrtho Cyclically Adjusted Price-to-FCF Chart

QuidelOrtho Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 112.71 87.24 40.89 16.51 13.50

QuidelOrtho Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.67 15.53 13.47 13.50 8.89

Competitive Comparison of QuidelOrtho's Cyclically Adjusted Price-to-FCF

For the Medical Devices subindustry, QuidelOrtho's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


QuidelOrtho's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, QuidelOrtho's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where QuidelOrtho's Cyclically Adjusted Price-to-FCF falls into.



QuidelOrtho Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

QuidelOrtho's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=40.80/4.96
=8.23

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

QuidelOrtho's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, QuidelOrtho's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.919/131.7762*131.7762
=-0.919

Current CPI (Mar. 2024) = 131.7762.

QuidelOrtho Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 -0.161 100.560 -0.211
201409 -0.038 100.428 -0.050
201412 0.363 99.070 0.483
201503 0.747 99.621 0.988
201506 -0.334 100.684 -0.437
201509 -0.203 100.392 -0.266
201512 0.318 99.792 0.420
201603 -0.263 100.470 -0.345
201606 0.047 101.688 0.061
201609 -0.131 101.861 -0.169
201612 0.362 101.863 0.468
201703 0.711 102.862 0.911
201706 -0.264 103.349 -0.337
201709 -0.302 104.136 -0.382
201712 0.160 104.011 0.203
201803 0.597 105.290 0.747
201806 0.415 106.317 0.514
201809 0.419 106.507 0.518
201812 0.706 105.998 0.878
201903 0.576 107.251 0.708
201906 0.721 108.070 0.879
201909 0.134 108.329 0.163
201912 0.815 108.420 0.991
202003 1.153 108.902 1.395
202006 1.045 108.767 1.266
202009 0.930 109.815 1.116
202012 7.733 109.897 9.273
202103 9.786 111.754 11.539
202106 -4.956 114.631 -5.697
202109 -0.598 115.734 -0.681
202112 5.800 117.630 6.498
202203 10.245 121.301 11.130
202206 3.550 125.017 3.742
202209 -0.602 125.227 -0.633
202212 1.517 125.222 1.596
202303 1.711 127.348 1.770
202306 -1.132 128.729 -1.159
202309 -0.027 129.860 -0.027
202312 0.437 129.419 0.445
202403 -0.919 131.776 -0.919

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


QuidelOrtho  (FRA:QL1A) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


QuidelOrtho Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of QuidelOrtho's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


QuidelOrtho (FRA:QL1A) Business Description

Traded in Other Exchanges
Address
9975 Summers Ridge Road, San Diego, CA, USA, 92121
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry and transfusion medicine which helps clinicians and patients to make better decisions across the globe. Geographically the company has its presence in North America, EMEA, China and Other countries. It generates majority if the revenue from North America.

QuidelOrtho (FRA:QL1A) Headlines

No Headlines